A Prospective Study on Gestosis Score as an Indicator of Hypertensive Disorder of Pregnangy in a Tertiary Care Center

Abstract

Background: Hypertensive disorders of pregnancy (HDP), particularly preeclampsia, remain a major cause of maternal and perinatal morbidity and mortality worldwide. Early identification of high-risk pregnancies is essential for timely intervention. The gestosis score has been proposed as a simple, cost-effective screening tool for predicting HDP.
Aim: To evaluate the utility of the gestosis score as an indicator for predicting hypertensive disorders of pregnancy in a tertiary care center.
Methods: This prospective study was conducted in the Department of Obstetrics and Gynecology at a tertiary care center from February 2024 to November 2025. A total of 100 pregnant women beyond 20 weeks of gestation were included. Gestosis scores were calculated based on predefined risk factors. Patients were categorized into low, moderate, and high-risk groups. Statistical parameters including sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and diagnostic accuracy were calculated.
Results: The majority of patients (72%) were categorized as high risk (gestosis score ≥3). Preeclampsia and severe preeclampsia accounted for a significant proportion of cases. The gestosis score demonstrated high sensitivity (94.74%) and good specificity (83.33%) in predicting preeclampsia. The PPV and NPV were 90% and 90.91%, respectively, with an overall diagnostic accuracy of 90.32% (p < 0.0001).
Conclusion: The gestosis score is an effective, simple, and reliable tool for early identification of women at risk of hypertensive disorders of pregnancy. It can be particularly useful in resource-limited settings for improving maternal and fetal outcomes through early intervention.
Keywords: Gestosis